Staphylococci are ubiquitous gram-positive cocci that frequently colonize the skin and mucous membranes of the respiratory, gastrointestinal, and urinary tracts, usually without causing overt disease (34, 41) . However, among the coagulase-negative staphylococci, Staphylococcus epidermidis has emerged as a significant cause of nosocomial bloodstream and biomaterial-centered infections (3, 8, 26, 45) , while Staphylococcus saprophyticus is a frequent cause of urinary tract infection, particularly in young females (31, 39, 62) . Coagulase-positive Staphylococcus aureus is a major human pathogen in superficial and deep-seated infections and can be a causal agent of tracheobronchitis or pneumonia, particularly in patients with influenza, in immunosuppressed patients, or in patients who are hospitalized (25, 38, 55, 64) . 5 . aureus is also an initial pathogen colonizing the respiratory tract of patients with cystic fibrosis (9, 33, 35, 43) , and, in a recent longitudinal study of sputa from 102 patients with cystic fibrosis, Bauernfeind et al. (5) reported the incidence of S. aureus and S. epidermidis isolation at -36%. The mechanism by which these staphylococci colonize mucosa in vivo is unknown.
The hydrophilic mucus gel coating, or partial coating (16) , of respiratory epithelium is generally considered to be a mechanical barrier to bacteria, facilitating their removal by mucociliary clearance (21, 40) . However, trapping in mucus gel may be a necessary first step in the infectious process of certain potentially invasive microorganisms or may, in fact, be the only way some bacteria associate with the mucosa (23) . The mechanism by which staphylococci colonize or infect mucosal surfaces is unknown. Presumably, cocci causing infection or chronic colonization of the lower respiratory tract are aspirates of microorganisms residing in mucus gel or on mucous membranes of the nasal cavity or nasopharynx.
In the present study, an in vivo ferret model was used to determine the association of S. aureus, S. epidermidis, and S. saprophyticus with mucosa of the nasal cavity. Also Mucin. The anterior and posterior turbinates were harvested from the left nasal fossa of eight ferrets, placed in Hanks balanced salt solution containing 0.5% lactoalbumin hydrolysate (Difco Laboratories, Detroit, Mich.) supplemented with penicillin (100 U/ml), streptomycin (100 ,ug/ml), and gentamicin (50 ,ug/ml), and stored at -70°C. A crude mucin preparation was made by using a modification of the procedure described by Roberts (47 Unbound bacteria were removed by aspiration, and the wells were gently washed 3 x with PBS; bacteria were removed by aspiration after each wash. Wells were examined by using an inverted microscope to determine whether all unbound staphylococci had been removed and whether wells required additional washes. Wells were drained, and each well was cut out and submerged in a 7-ml volume of Liquiscint scintillation cocktail (National Diagnostics, Manville, N.J.).
Radioactivity was determined in a scintillation spectrometer (Tracor). The dpms were converted to nanograms of staphylococci bound as previously described (52).
(ii) The method used for 3H-labeled S. aureus was modified to optimize binding of the staphylococci to immobilized mucin and minimize background binding to control wells. After blocking buffer was removed, each well was gently washed 3 x with PBS to remove any residual bovine serum albumin and wells were drained. Bacteria were thawed and washed 3 x with Tris hydrochloride buffer, pH 7.2 (25°C). A 50-pd volume of the staphylococci, suspended in Tris hydrochloride buffer, was added to each well, and the wells were incubated at 25°C for 60 min. Unbound bacteria were removed, and wells were processed as described above. All assays were done in triplicate.
Inhibitors. Washed 3H-labeled staphylococci were suspended in buffer, with or without inhibitors, and used in the in vitro assay.
bovine mucin, and a1-acid glycoprotein (human orosomucoid purified from Cohn fraction VI). In addition, TammHorsfall glycoprotein was purified from pooled human urine by repeated precipitation in 0.58 M NaCl as previously described (19, 20) and was used as an inhibitor.
Treatment of staphylococci. 3H-labeled staphylococci were rinsed 2 x in buffer and were suspended at a concentration of -0.5 to 1.5 mg (dry weight) of staphylococci per ml of buffer alone or buffer containing trypsin type 1 (from bovine pancreas), ,-galactosidase grade VIII (from Escherichia coli), and sodium metaperiodate, all of which were obtained from Sigma. The bacterial suspensions were incubated at 37°C for 60 min, except for bacteria suspended in the periodate solution, which were incubated in the dark at 25°C for 60 min. Treated bacteria and controls were washed 3 x, suspended in buffer, and used in the in vitro radioassay. PBS buffer was used for both S. epidermidis and S. saprophyticus, and Tris hydrochloride buffer was used for S. aureus for each treatment and wash.
STAPHYLOCOCCI BIND TO MUCIN 3737
Treatment of immobilized mucin. After the blocking step, each well was treated with a 100-,ul volume of trypsin type 1 in PBS, sodium metaperiodate in PBS, or receptor-destroying enzyme (from Vibrio comma; Whittaker M.A. Bioproducts, Walkersville, Md.) in calcium acetate saline (1), pH 6.2. Control wells were treated with the appropriate buffer solution only. After incubation at 37°C for 60 to 90 min, each well was aspirated, washed 3x with PBS, and used in the in vitro radioassay as described.
Statistical analysis. The arithmetic means, standard deviations, and standard errors of the means were determined for each set of data. Where appropriate, the coefficient of variation was determined and comparisons were made by a single-factor analysis of variance by using the StatView 512+ computer package (BrainPower, Calabasas, Calif.).
RESULTS
Growth conditions of staphylococci. Bacteria were labeled in a chemically defined tissue culture medium to avoid adsorption of protein components, conceivably present in a biologically complex medium, to the surface of bacteria. After growing for 18 h, S. epidermidis and S. saprophyticus were present as floccules that rapidly settled out of solution, while S. aureus formed floccules in early exponential growth phase that appeared to dissolve as the cocci reached the stationary phase of growth and the pH of the growth medium became acidic. The starting pH of the medium appeared to be critical for the formation of floccules and for the subsequent binding of all three test strains of staphylococci to mucin in vitro.
Distribution of staphylococci in vivo. Results of the in vivo radioassay are shown in Fig. 1 . Of the total amount of labeled staphylococci introduced into the right nasal fossa, 8.1% of the S. saprophyticus inoculum was recovered from the four tissues harvested, versus 6.8% of the S. epidermidis and 5.4% of the S. aureus inocula. A total of 94.4% of recoverable S. saprophyticus was associated with the anterior turbinate. Similarly, 81.1% of recoverable S. epidermidis was associated with the anterior turbinate and 18.1% with the posterior turbinate. With S. aureus, the amount recovered from the anterior and posterior turbinates was 53.7 and 43%, respectively. The amount of cell-free label represented -0.5% of the total inoculum with all three test strains. Storage conditions of the staphylococci made a significant difference in their capacity to associate with tissues of the upper respiratory tract. When freeze-dried bacteria were substituted for the fresh frozen staphylococci (as seen in Fig. 1 ), association with anterior turbinates was decreased 10-fold with S. aureus and -200-fold with both S. epidermidis and S. saprophyticus (data not shown).
Association of staphylococci with mucus gel in vivo. The in vivo radioassay indicated the distribution and level of association of staphylococci with tissues of the nasal fossa; however, histological examination was able to define the nature of this association. Figure 2A shows the normal architecture of the anterior nasal turbinate, in which the air passages are lined with respiratory mucosa. The three test strains of staphylococci were seen only in association with mucus gel overlaying cilia of the columnar epithelial cells, as represented in Fig. 2B , or attached to mucus strands released into the air passage ( Fig. 2A and B ). Staphylococci were not observed interacting directly with host cells of the turbinate, even in areas where the epithelium appeared to be mucus free (Fig. 2A) . The association of staphylococci with mucus was typical for all tissues examined except the Inhibition of binding by mucin. Binding of staphylococci to immobilized FM and BM was significantly inhibited when bacteria suspended in BM were used in the in vitro radioassay (Table 1) . A sufficient amount of FM was not available for use in the inhibition assay. Specificity of binding was indicated by the fact that human Tamm-Horsfall urinary mucin and orosomucoid did not significantly block binding of the staphylococci (Table 1) .
Inhibition of binding by sugars. With one exception, the binding of staphylococci to immobilized mucin was not significantly inhibited when bacteria suspended in solutions of neutral and amino sugars were used in the in vitro assay ( Table 2 ). The presence of N-acetylneuraminic acid did block binding of S. epidermidis to BM, but at a very low level. In the presence of amino sugars, S. saprophyticus exhibited a tendency to clump, which may account for the significant (P = 0.01) increase in binding to both FM and BM.
Characterization of mucin receptor(s). Treatment of immobilized mucin with trypsin significantly decreased subsequent binding of staphylococci (Table 3) , which suggests that the mucin receptor has a protein component. In addition, oxidation of sugars in mucin by sodium metaperiodate decreased binding of S. epidermidis (P = 0.002) to BM, which suggests that a glycoprotein component may contribute to the binding of S. epidermidis.
Characterization of staphylococcal receptor(s). Table 4 summarizes the results obtained when 3H-labeled staphylococci were subjected to various agents and treatments before being used in the in vitro radioassay. Compared with untreated controls, the binding of all three test strains of staphylococci to FM and BM was significantly reduced when the bacteria were treated with trypsin, which suggests that the surface receptors may have protein components. Binding to BM was significantly enhanced by treatment of S. saprophyticus with P-galactosidase (P = 0.006); one possibility is that this enzyme treatment actually unmasked receptors on the bacterial cell surface.
DISCUSSION
In the present investigation, localization of S. aureus, S. epidermidis, and S. saprophyticus in the upper respiratory tract (nasal fossae) was studied in a ferret model. All three strains appeared to bind to the keratinized lining of the anterior vestibule. These observations are similar to those previously reported for S. aureus in ferrets, uninfected and infected with influenza A virus (53) , and with cell scrapings from the anterior nares of human subjects (7) . Once past the nasal vestibule, however, the keratinized tissue is replaced by a thin layer of mucus that covers the epithelial-cell lining of respiratory mucosa. It was in this mucus that .96% of the 50 ,ul of buffer per well) were added to wells of immobilized mucin or to control wells without mucin. Bars represent standard error of the means of triplicate samples. Note that the scales are different for panels A, B, and C. Specific activity: 5,874 dpm/,ug (dry weight), S. epidermidis; 3,325 dpm/ jLg (dry weight), S. saprophyticus; and, 12,276 dpm/,ug (dry weight), S. aureus. recoverable staphylococci localized ( Fig. 1 and 2) . Areas of the mucosa that appeared to be mucin free were also free of staphylococci (Fig. 2) , which suggested that nasal mucus contained staphylococcus-binding components that were not present on respiratory epithelial cells. In fact, Tuomanen (53) . While mucus may act to trap and clear staphylococci from the respiratory tract, it is also possible that staphylococcal binding to mucus may be a mechanism for respiratory mucosal colonization similar to the mucus colonization of intestinal mucosa by Campylobacter jejunum (37) . Airway mucus, typically comprised of salts, plasma and nonplasma proteins, glycoproteins (mucin), lipids, and H20 (14, 48) , is rich in potential receptors for bacteria. Particular bacteria, including S. aureus (50) , have been shown to have a high avidity for mucin in the upper respiratory tract (32) , the intestinal tract (13) , and saliva (65) ; the interaction may be highly specific for a particular mucin (17) and may involve multiple receptors (61) . Vishwanath and Ramphal (60) ( Fig. 3) . Trypsin treatment of the mucin significantly reduced staphylococcal binding, by .42% (Table 3) , which suggests that receptors are positioned on the segment of peptide core unprotected from enzyme attack by carbohydrate side chains. To a lesser extent, periodate treatment of BM, but (11) and S. saprophyticus (27) ; whether these host cell and mucin receptors are similar or distinct is unknown, but the subject merits further study.
Specificity of the radioassay was tested in a series of blocking experiments. As expected, BM blocked the binding of staphylococci to immobilized BM; in addition, binding to FM was also blocked (Table 1) . When human orosomucoid and Tamm-Horsfall urinary mucin were substituted for BM, binding was not significantly inhibited ( Table 1 ). The in vitro radioassay was also used to characterize staphylococcal receptors responsible for mucin binding. Clearly, the binding of S. aureus to crude FM was considerately less than that obtained with S. epidermidis and S. saprophyticus (Fig. 3) , which may reflect a quantitative or qualitative difference between surface receptors. In contrast to S. epidermidis and S. saprophyticus, the interaction of S. aureus with BM was not significantly and consistently above binding to control wells; increasing the concentration of S. aureus did increase binding to BM, but it also increased background binding. Possibly, test conditions were not optimal, because BM can coat S. aureus and significantly decrease binding to FM ( Table 1 ). The FM-binding receptor of S. aureus was sensitive to trypsin treatment and resistant to treatment with ,-galactosidase and sodium metaperiodate (Table 4) , which suggests that the receptor has a protein component. At present it is unknown whether this mucin-binding receptor is similar to previously described surface proteins of S. aureus that mediate binding to fibrinogen (18) , fibronectin (24) , laminin (42) , collagen (29) , influenza A virus-infected and control cell monolayers (15, 51) , the Fc piece of immunoglobulins (22) , or silicone polymers (4) . Surface proteins of other bacteria have been reported as receptors for mucin binding. For example, pili appear to play an important role in the binding of nonmucoid P. aeruginosa to respiratory mucin (46) and of E. coli to urinary (36, 44) and intestinal (61) mucin and saliva (28) . For S. aureus, the mucin-binding receptor does appear to be distinct from the lipoteichoic acid adhesin (10) which mediates S. aureus adherence to human buccal cells (in vitro) and the teichoic acid component (2, 6) reported to be one of the adhesins mediating attachment of S. aureus to human nasal mucosal cells (in vitro).
The mucin-binding receptors of both S. epidermidis and S. saprophyticus were sensitive to treatment with trypsin, which again suggested that the receptors were composed of protein components (Table 4 
